Shares of CERo Therapeutics Holdings, Inc. (NASDAQ:CERO – Get Free Report) dropped 3.2% on Thursday . The stock traded as low as $1.40 and last traded at $1.41. Approximately 73,320 shares were traded during mid-day trading, a decline of 93% from the average daily volume of 982,370 shares. The stock had previously closed at $1.46.
CERo Therapeutics Stock Down 2.8 %
The stock’s 50-day moving average is $2.37.
About CERo Therapeutics
CERo Therapeutics Holdings, Inc, an immunotherapy company, focuses on advancing the development of engineered T cell therapeutics for the treatment of cancer. Its lead program in hematologic malignancies targets an Eat Me signal upregulated on B cell and myeloid tumors. The company is based in South San Francisco, California.
See Also
- Five stocks we like better than CERo Therapeutics
- Investing In Automotive Stocks
- MarketBeat Week in Review – 4/22 – 4/26
- P/E Ratio Calculation: How to Assess Stocks
- 3 Stocks Leading the U.S. Agriculture Comeback
- ETF Screener: Uses and Step-by-Step Guide
- How to Use Put Debit Spreads to Profit From Falling Stocks
Receive News & Ratings for CERo Therapeutics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CERo Therapeutics and related companies with MarketBeat.com's FREE daily email newsletter.